Permeability of a capsaicin derivative, [14C]DA-5018 to blood-brain barrier corrected with HPLC method

Archives of Pharmacal Research

Volumn 22, Issue 2, 1999, Pages 165-172

  Kang, Young Sook ^a   Kim, Jong Mi ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

Blood brain barrier; Capsaicin; DA 5018; Vanilloid receptor

Indexed keywords

ANALGESIC AGENT; CAPSAICIN; CAPSAVANIL; CARBON; DIAGNOSTIC AGENT; DRUG DERIVATIVE;

ANIMAL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; METABOLISM; PERMEABILITY; RAT; SPRAGUE DAWLEY RAT;

ANALGESICS, NON-NARCOTIC; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CAPSAICIN; CARBON RADIOISOTOPES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MALE; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0033111088     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02976541     Document Type: Article

References (27)

1. Lundberg, J. M. and Saria, A., Polypeptide-containing neurons in airway smooth muscle. Annu. Rev. Physiol. 49, 557-572 (1987).
2. Hokfelt, T., Johansson, O., Ljungdahl, A. and Lundberg, J. M., Peptidergic neurons. Nature 284, 515-521 (1980).
3. Saria, A., Martling, C. and Van, Z., Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, dimethylphenyl piperazinium and vagal nerve stimulation. Am. Rev. Respir. 41, 167-172 (1988).
4. LaHann, T. R., Antinociceptive actions of capsaicin in rodents. Proc. West. Pharm. Soc. 26, 145-149 (1983).
5. Holzer, P., Capsaicin; Cellular targets, mechanisms of action and selectivity for thin sensory neurons. Pharmacol. Rev. 43, 143-201 (1991).
6. Park, N. S., Ha, D. C., Choi, J. K. and Kim, H. S., Phenylacetamide derivatives and pharmaceutical compositions thereof. U. S. Patent No. 5, 242, 944 (1993).
7. Bernstein, J. E., Korman, N. J. and Bickers, D. R., Topical capsaicin treatment of chronic postherpetic neuralgia. J. Am. Acad. Dermatol. 21, 265-270 (1991).
8. Ross, D. R. and Varipapa, R. J., Treatment of painful diabetic neuropathy with topical capsaicin. N. Eng. J. Med. 321, 474-475 (1989).
9. McCarthy, G. W. and McCarthy, D. J., Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J. Rheumatol. 19, 604-607 (1992).
10. Lee, B., Kim, J. H., Park, N. S. and Kong, J. Y., KR-25018; A Novel, orally active analgesic with non-narcotic properties. Arch. Pharm. Res. 17: 304-308 (1994).
11. Reid, J. and McCulloch, J., Capsaicin and blood-brain barrier permeability. Neurosci. Lett. 81, 165-170 (1987).
12. 3H]Resiniferatoxin binding to central (spinal cord and dorsal root ganglion) and peripheral urinary bladder and airways) vanilloid (capsaicin) receptors in the rat. J. Pharmacol. Exp. Ther. 267, 728-733 (1993).
13. Gibaldi, M. and Perrier, D., Pharmacokinetics, Marcel Dekker, Inc., New York, 1982.
14. Shim, H. J., Lee, J. J., Lee, S. D. and Kim, W. B., Determination of a new non-narcotic analgesic DA-5018, in plasma, urine and bile by HPLC. J. Chromatogr. B. Biomed. Appl. 689, 422-426 (1997).
15. Takasato, Y., Rapoport, S. I. and Smith, Q. R., An in situ brain perfusion technique to study cerebrovascular transport in the rat. Am. J. Physiol. 247, H484-493 (1984).
16. Triguero, D., Buciak, J. B. and Pardridge, W. M., Capillary depletion method for quantifying blood-brain barrier transport of circulating peptides and plasma protein. J. Neurochem. 54, 1883-1888 (1990).
17. Pardridge, W. M., Kang, Y. S. and Buciak, J. L., Transport of human recombinant brain-derived neurotrophic factor (BNDF) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery. Pharm. Res. 11, 738-746 (1994).
18. Broadwell, R. D., Salcman, M. and Kaplan, R. S., Morphologic effect of dimethyl sulfoxide on the blood-brain barrier. Science 21, 164-166 (1982).
19. W. Michael Scheld. Drug delivery to the central nervous system; General principles and relevance to therapy for infections of the central nervous system. Rev. Infec. Disea. 11, S1669-S1690 (1989).
20. Samii, A., Bickel, U., Stroth, U. and Pardridge, W. M., Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogue. Am J. Physiol. 267, E124-E131 (1994).
21. Nutt, J. G., Hammerstad, J. P. and Woodward, W. R., The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. N. Engl. J. Med. 310, 483-488 (1984).
22. Sved, A. F., Goldberg, I. M. and Fernstrom, J. D., Dietary protein intake influences the antihypertensive potency of methyldopa in spontaneously hypertensive rats. J. Pharmacol. Exp. Ther. 214, 147-151 (1980).
23. Pardridge, W. M., Brain metabolism; a perspective from the blood-brain barrier. Physiol. Rev. 63, 1481-1535 (1983).
24. Betz, A. L., Csejtey, J. and Goldstein, G. W., Hexose transport and phosphorylation by capillaries isolated from rat brain. Am. J. Physiol. 236, C96-102 (1979).
25. Brust, P., Changes in regional blood-brain transfer of L-leucine elicited by arginine-vasopressin. J. Neurochem. 46, 534-541 (1986).
26. Goldstein, G. W. and Betz, A. L., The blood-brain barrier. Sci. Am. 255, 74-83 (1986).
27. Wu, D., Kang, Y. S., Bickel, U. and Pardridge, W. M., Blood-brain barrier permeability to morphine-6-glucuronide is markedly reduced compared with morphine. Drug Metab. Dispos. 25, 768-771 (1997).